Minerva Neurosciences, Inc

As of June 30, 2026, Minerva Neurosciences Inc carries a market capitalization of 230.75M, placing it among publicly traded companies globally. Its enterprise value stands at 164.87M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Minerva Neurosciences Inc's next confirmed earnings release is scheduled for November 11, 2026.

As of June 30, 2026, Minerva Neurosciences Inc has 47.23M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Minerva Neurosciences Inc maintains a current ratio of 20.14, meaning it holds 20.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -628.40, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 7.25, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Minerva Neurosciences Inc's stock has declined approximately 53.28% over the past 52 weeks. The 50-day moving average sits at 3.30, while the 200-day moving average is 4.27.

Over the twelve months ended June 30, 2026, Minerva Neurosciences Inc generated - - in revenue and converted that into -345.17M in net income, yielding earnings per share of -9.74. EBITDA reached -30.76M, while operating income came in at -30.76M.

These figures are as of June 30, 2026. Total book value stands at -186.70M, with working capital of 66.33M providing operational flexibility.

Minerva Neurosciences Inc produced -22.91M in operating cash flow over the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -13.23: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -32.51, meaning Minerva Neurosciences Inc raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Minerva Neurosciences Inc's most recent stock split took place on June 21, 2022 with a 8:1 split ratio.

As of June 30, 2026, Minerva Neurosciences Inc has an Altman Z-Score of -13.70, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.